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Abstract
Background: Two Kato-Katz thick smears (Kato-Katzs) from a single stool are currently recommended for diagnosing
Schistosoma mansoni infections to map areas for intervention. This ‘gold standard’ has low sensitivity at low infection
intensities. The urine point-of-care circulating cathodic antigen test (POC-CCA) is potentially more sensitive but how
accurately they detect S. mansoni after repeated praziquantel treatments, their suitability for measuring drug efficacy and
their correlation with egg counts remain to be fully understood. We compared the accuracies of one to six Kato-Katzs and
one POC-CCA for the diagnosis of S. mansoni in primary-school children who have received zero to ten praziquantel
treatments. We determined the impact each diagnostic approach may have on monitoring and evaluation (M&E) and drug-
efficacy findings.
Method/Principle Findings: In a high S. mansoni endemic area of Uganda, three days of consecutive stool samples were
collected from primary school-aged children (six - 12 years) at five time-points in year one: baseline, one-week-post-, four-
weeks-post-, six-months-post-, and six-months-one-week-post-praziquantel and three time-points in years two and three:
pre-, one-week-post- and four-weeks-post-praziquantel-treatment/retreatment (n = 1065). Two Kato-Katzs were performed
on each stool. In parallel, one urine sample was collected and a single POC-CCA evaluated per child at each time-point in
year one (n = 367). At baseline, diagnosis by two Kato-Katzs (sensitivity = 98.6%) or one POC-CCA (sensitivity = 91.7%,
specificity = 75.0%) accurately predicted S. mansoni infections. However, one year later, a minimum of three Kato-Katzs, and
two years later, five Kato-Katzs were required for accurate diagnosis (sensitivity .90%) and drug-efficacy evaluation. The
POC-CCA was as sensitive as six Kato-Katzs four-weeks-post and six-months-post-treatment, if trace readings were classified
as positive.
Conclusions/Significance: Six Kato-Katzs (two/stool from three stools) and/or one POC-CCA are required for M&E or drug-
efficacy studies. Although unable to measure egg reduction rates, one POC-CCA appears to be more sensitive than six Kato-
Katzs at four-weeks-post-praziquantel (drug efficacy) and six-months-post-praziquantel (M&E).
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Introduction
Schistosomiasis remains a major public health concern despite
praziquantel reaching over 30 million people in endemic areas in
2013 [1]. Goals to eliminate schistosomiasis by 2020 have been
articulated by the World Health Organization’s (WHO) ‘Road-
map for Neglected Tropical Disease (NTD) Implementation’ [2],
and the London Declaration of the NTD Coalition [3]. Accurate
diagnostic techniques, recently highlighted by Gomes and
colleagues [4], are essential for monitoring and evaluation
(M&E) of mass drug administration (MDA) programs at all stages
[5–9], and particularly when considering elimination [2,10,11]
and/or drug-resistance pharmacovigilance [12,13].
The WHO recommends two Kato-Katz thick smears (Kato-
Katzs) from a single stool [14] for Schistosoma mansoni diagnosis
to determine prevalence to map areas for control interventions
[15]. Kato-Katzs have assumed 100% specificity, but large inter-
and intra-specimen variation [16–18] and low sensitivity for the
detection of low intensity infections have been reported [19–21].
In Brazil, where M&E programs use only one Kato-Katz, S.
mansoni prevalence has been significantly underestimated in low
intensity regions [22,23]. This may be associated with overesti-
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mated cure rates (CRs) and praziquantel efficacy [24], potentially
missing drug resistance. Conversely, using one Kato-Katz can
overestimate infection intensities [22]. These differences in
sensitivity for prevalence versus infection intensity highlight
complex interactions with egg reduction rates (ERRs) as true
intensities decrease. Inter-day variation of excreted egg numbers
post-treatment remains poorly understood. Two Kato-Katzs are
commonly used for annual M&E of program impact and/or drug-
efficacy studies, without being rigorously tested in these scenarios.
Detailed analyses of the sensitivity and specificity of single and
multiple Kato-Katzs following praziquantel treatment is urgently
required.
It is not possible to directly measure S. mansoni adult worm
numbers, due to their location in the mesenteric system, with eggs
counted from Kato-Katzs used as a proxy for infection intensity.
Immunodiagnostics for adult worm circulating cathodic antigens
(CCA) or circulating anodic antigens (CAA) detect current
infections and are potentially more sensitive for diagnosis of cases
in low transmission areas [25–27]. Recent developments using
innovative immunomagnetic separation with several target CCAs
[28] and novel monoclonal antibody diagnostics for serum CCA
[27] show high sensitivity even in low endemic areas. Serum CAA
tests are more accurate than urine CAA tests [29], with advances
made on a, not yet commercially available, point-of-care-CAA
(POC-CAA) [30]. In contrast, urine CCA tests were more
accurate than serum CCA tests [29]. Being easier to collect and
more socially acceptable than stool or blood, urine POC-CCAs
were developed for rapid, non-invasive diagnostics and proposed
as alternatives to Kato-Katzs for S. mansoni prevalence mapping
[31–37]. One urine POC-CCA is as sensitive as two Kato-Katzs
for S. mansoni diagnosis for prevalence mapping [35] or two years
post-treatment [36] and has now been used to map S. mansoni
prevalence in low intensity areas in Uganda [37]. Major POC-
CCA limitations are their ability to only semi-quantitatively
measure infection intensity [32,34,38], inaccuracy for S. haema-
tobium infection detection [39,40], and not measuring
soil-transmitted helminth (STH) infections. Intensity of infection
measures are vital for control program M&E and drug-efficacy
evaluation. Therefore knowledge on the ability of POC-CCAs to
detect S. mansoni intensity reductions is essential [34–36,41].
We compared the accuracy of the currently available POC-
CCA and one to six Kato-Katzs (two smears per day from three
consecutive stool samples) for S. mansoni diagnosis, in primary-
school children in Mayuge District, Uganda, at baseline and after
up to ten praziquantel treatments per child over three years
(STARD Checklist S1 and Figure 1). We evaluated the epidemi-
ological implications of diagnostic methods for control program
M&E and praziquantel-efficacy studies. We inform on the number
of Kato-Katzs required to accurately detect S. mansoni infections
pre- and post-praziquantel treatment and whether POC-CCAs are
suitable alternatives. Our detailed longitudinal design enabled
novel investigations into individuals’ recent versus total prazi-
quantel treatments, aiding biological understanding of differences
between Kato-Katz and POC-CCA results post-praziquantel
treatment. We predicted that the accuracy of M&E and drug-
efficacy findings are limited by Kato-Katz sensitivity at low
infection intensities post-treatment. We also predicted that a single
POC-CCA would have a higher sensitivity than multiple Kato-
Katzs, and be more informative for prevalence monitoring as
control programs progress.
Materials and Methods
Ethics Statement
Approvals were granted by the Uganda National Council of
Science and Technology (Memorandum of Understanding:
sections 1.4, 1.5, 1.6) and the Imperial College Research Ethics
Committee (EC NO: 03.36. R&D No: 03/SB/033E). Verbal
assent was given by every child before inclusion into this study and
at school committee meetings comprising of parents, teachers, and
community leaders before the onset of the study. Written consent
for the children to participate in the study was attained from each
head teacher. Participation was voluntary and children could
withdraw or be withdrawn from the study at any time without
obligation. Children were treated with 40 mg/kg praziquantel and
400 mg albendazole (active against STH infections) as detailed
below.
Study Area
Samples were collected, between 2004 to 2006, from primary-
school children, in a high S. mansoni-endemic area, in Mayuge
district, Uganda from three schools on the shores of Lake Victoria:
Bugoto Lake View, Bwondha, and Musubi Church of God.
Children at Musubi were, to the authors’ knowledge, praziquantel-
naı¨ve. Children at Bugoto and Bwondha had received 40 mg/kg
praziquantel one year previously in 2003 [42]. Inclusion criteria
were to have lived in the area since birth and to attend the schools
sampled.
Study Cohort and Treatment
In 2004, samples were collected at five time-points: baseline,
one-week-post-, four-weeks-post-, six-months-post- and six-
months-one-week-post-praziquantel treatment (Figure 1). In
2005 and 2006, samples were collected pre-, one-week-post-,
and four-weeks-post-praziquantel re/treatment. On the third day
of sampling, at baseline, six-months, one-year, and two-years all
children were treated with 40 mg/kg praziquantel and 400 mg
albendazole (active against STH infections). At one-week post-
treatment, children with infections of .100 S. mansoni eggs per
gram of stool (EPG) were retreated with 40 mg/kg praziquantel.
Author Summary
Schistosomiasis is a parasitic disease infecting over 200
million people. It remains a major public health concern
despite treatment of over 120 million people in sub-
Saharan Africa alone. Accurate diagnostic methods are
essential for monitoring drug efficacy and long-term
control program success. The World Health Organization
recommends two Kato-Katz thick smears (Kato-Katzs) from
a single stool for Schistosoma mansoni diagnosis to map
prevalence and areas for control interventions. Although
highly specific, Kato-Katzs are thought to be insensitive at
low egg counts. The recently refined urine point-of-care
circulating cathodic antigen test (POC-CCA) has been
proposed as a diagnostic alternative for mapping areas for
interventions, and potentially for assessing drug efficacy.
Over three years we assessed the accuracy of six Kato-
Katzs and a single POC-CCA in detecting infections in
Ugandan primary-school children at 11 time points with
repeated praziquantel treatments. Our results demonstrate
that two Kato-Katzs accurately detect S. mansoni infection
pre-treatment, but at least three days of two Kato-Katzs
per stool or one POC-CCA are required for annual
monitoring and treatment evaluation and/or drug-efficacy
studies. One POC-CCA may be more sensitive in measuring
S. mansoni prevalence than six Kato-Katzs, but its
accuracies for rigorous intensity measures are still to be
proven.
Test Accuracy for S. mansoni Diagnosis Pre- and Post-treatment
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At all other time-points all children with positive diagnoses for S.
mansoni or STHs were retreated with 40 mg/kg praziquantel and
400 mg albendazole respectively.
Cohort and sample collection are described elsewhere [43]. In
brief, 110 children from Bugoto, 110 from Bwondha and 68 from
Musubi were recruited in 2004 with an equal sex ratio, aged six to
12 years, without prior knowledge of infection status and/or
symptoms of S. mansoni infection. In addition, at one- and two-
years, 30 praziquantel-naı¨ve six year old children were recruited at
each school and followed up with the original cohorts at the time
points described above. This enabled monitoring of the impact of
MDA on untreated children entering the school system, assessing
diagnostic accuracies for Kato-Katzs and POC-CCA, in prazi-
quantel-naı¨ve and praziquantel-exposed children, as control
programs progress.
Intensity of Infection and Prevalence Measures
Diagnostic accuracy increases with the number of Kato-Katzs,
however, in Brazilian low intensity regions, the additional benefit
of more than six Kato-Katzs from repeated stools was negligible
[21], supporting our six Kato-Katzs ‘gold standard’. Stool samples,
marked with unique child IDs, were collected on three consecutive
days, between 10:00 and 12:00 hours. Two 41.7 mg Kato-Katzs
were prepared per stool and read onsite using a compound
microscope with natural light source, by highly trained personnel
from the Ugandan Vector Control Division, Ministry of Health. S.
mansoni, hookworm, Ascaris lumbricoides, and Trichuris trichiura
egg counts were recorded. Five percent of slides were reread after
the study for S. mansoni, A. lumbricoides, and T. trichiura egg
counts for quality control, but no significant differences were
observed. One urine sample per child was collected between 10:00
and 12:00 hours on the first day. In the first year, at all five time-
points, POC-CCAs (European Veterinary Laboratory, The
Netherlands) were performed, according to the producer’s
protocols, by the first author, blind of other test results.
Microhematuria was tested for using Hemastix (Bayer, United
Kingdom).
Statistical Analysis
SPSS version 19 (SPSS, Inc., Chicago, IL, United States of
America) was used for all statistical analyses. The double entered
data were not normally distributed and could not be normalized
Figure 1. Recruitment and inclusion of primary-school children and their samples in the study. Final numbers of children who provided
three stools for a total of six Kato-Katz thick smears (6KK) and one urine sample for a point-of-care circulating antigen test (POC-CCA) at each time-
point. Final numbers and percentage female in parentheses. Totaling 1065 samples for Kato-Katz thick smears accuracy analyses and 367 for POC-
CCA analyses over the whole study. Samples were collected pre-praziquantel treatment, one-week-post-praziquantel treatment (1 Wk-Post-Treat)
and four-weeks-post-praziquantel treatment (4 Wks-Post-Treat) at four time points: Baseline, six months later, one year later and two years later.
doi:10.1371/journal.pntd.0003139.g001
Test Accuracy for S. mansoni Diagnosis Pre- and Post-treatment
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by transformation, therefore non-parametric tests were used.
Individuals without the full six Kato-Katzs were excluded from the
study (Figure 1). Arithmetic mean infection intensities were
categorized as by the WHO (S. mansoni: light = 1–99 EPG,
moderate = 100–399 EPG and high $400 EPG; A. lumbricoides:
light = 1–4999 EPG; Hookworm: light = 1–1,999 EPG; T. tri-
chiura: light = 1–999 EPG) [15]. Exact confidence intervals (CIs)
were calculated for prevalence measures and standard errors for
EPGs.
Inclusion bias and potential confounders. There were no
significant differences between the final dataset (six Kato-Katzs)
and the excluded dataset (,six Kato-Katzs) in S. mansoni
intensities (Mann Whitney: U = 509672.5, d.f. = 1420, p= 0.12),
STH presence (x2 = 0.90, d.f. = 2, p= 0.34) or microhematuria
(x2 = 1.51, d.f. = 4, p= 0.83). It was therefore assumed that the
final dataset was not biased by missing data. There were no
significant differences in accuracies of POC-CCAs, with trace
counted as negative (POC-CCA-t2) (Fisher’s exact: PA = 0.91,
PB = 0.91) or positive (POC-CCA-t+) (PA = 0.93, PB = 0.87)
between those infected with STHs (n = 107) or not (n = 260). A
greater proportion of the microhematuria positive samples
(19/367, of which 17 were female) were POC-CCA negative
than expected (x2 = 17.62, d.f. = 2, p,0.001), although micro-
hematuria was not thought to have biased results, with 12
negative, two trace, four positive (+) and one double positive (++)
POC-CCA observed. All urine samples were screened for S.
haematobium but no eggs were observed, confidently excluding S.
haematobium co-infections.
Diagnostic accuracy of tests pre- and post-praziquantel-
treatment. The sensitivity, specificity, positive predictive value
(PPV) and negative predictive value (NPV) of POC-CCA-t+,
POC-CCA-t2, and one to five Kato-Katzs were calculated with
95% exact CIs. Differences in sensitivity between our six Kato-
Katzs ‘gold standard’ and the current recommended two Kato-
Katzs or one POC-CCA were determined using the McNemar
test. The agreement between six Kato-Katzs and two Kato-Katzs
or POC-CCA were assessed using Kappa (k) statistics: k,0.01 no
agreement; k= 0.01–0.2 poor; k= 0.21–0.4 fair; k= 0.41–0.6
moderate; k= 0.61–0.8 substantial; k= 0.81–1 almost perfect [44].
Accuracies were also calculated for POC-CCA and one to six
Kato-Katzs, using the combined ‘gold standard’ of POC-CCA-t+
and six Kato-Katzs [41]. Finally, the accuracies of one to five
Figure 2. Sensitivity and negative predictive values of one to five Kato-Katzs for S. mansoni diagnosis. (A) Sensitivity and (B) Negative
Predictive Values of one to five Kato-Katzs thick smears (1KK to 5KK) for S. mansoni diagnosis over 11 time-points using six Kato-Katzs as the ‘gold
standard’. All individuals were treated with 40 mg/kg praziquantel after the start of the study (pre) and then again at six-months, one-year and two-
years. All individuals providing stool samples with .100 eggs per gram (EPG) at one-week-post-praziquantel treatment and any infected children at
all other time-points were re-treated with 40 mg/kg praziquantel. 95% confidence intervals are excluded for clarity, but can be seen in Table 2.
doi:10.1371/journal.pntd.0003139.g002
Test Accuracy for S. mansoni Diagnosis Pre- and Post-treatment
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Kato-Katzs and POC-CCA were calculated over time since each
individual had first ever been treated, to explore differences
between community and individual treatment history on diagnos-
tic accuracies.
Effect of mean infection intensity on accuracy. Data from
each school, at each time-point, were used to compare sensitivities
of one to five Kato-Katzs against school arithmetic mean EPG,
using Spearman’s rank correlation. Five best fit linear lines (for one
to five Kato-Katzs) were calculated. The mean distance of data-
points from these lines were compared, using Mann-Whitney,
between two data-subsets to test whether the distance was greater
for time-points one- or four-weeks-post-praziquantel in compar-
ison to ‘pre-praziquantel’ (pre, six-months, one-year and two-
years). No significant differences were found (all p.0.05) and data-
points were combined for analysis of the effect of infection
intensity.
Effect of diagnostic test on treatment efficacy and
reinfection measures. Cure rates were determined, for each
diagnostic method, as the proportion of S. mansoni-positive
individuals at baseline who were negative four-weeks-post-
praziquantel. Odds ratios were calculated for comparisons of
prevalence at each time-point. Comparisons of infection intensi-
ties, over three days of Kato-Katzs, were performed using the
Friedman test for repeated measures.
Ability of Kato-Katzs and POC-CCA to measure infection
intensity pre- and post-praziquantel. Band strengths of the
POC-CCAs (negative, trace, +, ++ and +++) were compared with
Kato-Katz infection intensity categories and individual children’s
arithmetic mean EPG using Spearman’s rank coefficient.
Results
There were 1065 samples with six Kato-Katzs and 367 samples
with six Kato-Katzs and a POC-CCA result (Figure 1). Baseline S.
mansoni prevalence (x2 = 0.38, d.f. = 2, p= 0.83) and EPG
intensity (Kruskal-Wallis: H = 3.416, d.f. = 2, p= 0.18) were not
significantly different between schools and all statistics were
performed on the combined data. Baseline prevalence in the
main (six Kato-Katzs) dataset was 94.8% with an arithmetic mean
infection intensity of 249.8 EPG, similar to the POC-CCA dataset
prevalence (94.7%) and intensity (259.0 EPG) (Table 1). Hook-
worm prevalence was 51.0%, whilst A. lumbricoides and T.
trichiura infections were low at 1.0% and 9.4%, respectively
(Table 1). S. mansoni prevalence at baseline, as recorded by POC-
CCA-t+ and POC-CCA-t2 was 88.2% and 78.9%, respectively
(Table 1).
Diagnostic Accuracies Pre- and Post-Praziquantel-
Treatment
Kato-Katz. There were no significant differences between
the sensitivity and NPV of one to five Kato-Katzs between the
POC-CCA and Kato-Katzs only datasets (all p.0.05) (Fig-
ure 2, Tables 2 and 3). At baseline, 97% of S. mansoni
infections were detected by two Kato-Katzs, reaching 100%
with a second day of sampling (Figure 2). At one-week-post-
praziquantel, sensitivity of two Kato-Katzs was approximately
90%. However, by four-weeks-post-praziquantel, nearly half of
infected individuals were wrongly classified as uninfected with
the sensitivity of two Kato-Katzs being only 51.9%. Four
Kato-Katzs had a higher sensitivity of 77.8%, but five Kato-
Katzs were required for sensitivities above 90% at four-weeks-
post-praziquantel. The sensitivity of two Kato-Katzs at six-
month-post-praziquantel was 74.0%, but five Kato-Katzs were
required to reach sensitivities above 90%. As praziquantel
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treatments continued, the sensitivities of one to five Kato-
Katzs remained systematically lower than at baseline (Fig-
ure 2A, Tables 2 and 3).
At baseline, only a quarter of the individuals found to be
negative by one Kato-Katz were negative for six Kato-Katzs, with
three Kato-Katzs required for a NPV of 100% (Figure 2B,
Tables 2 and 3). In each year of the study, NPVs peaked four
weeks after treatment, but were at their lowest immediately before
the next round of treatment (Figure 2B, Table 2).
The sensitivity of one to four Kato-Katzs was positively
correlated with the mean infection intensity for one Kato-Katz
(r = 0.539, p = 0.001); two Kato-Katzs (r = 0.427, p = 0.02);
three Kato-Katzs (r = 0.424, p = 0.02); four Kato-Katzs
(r = 0.384, p = 0.03), but not five Kato-Katzs (r = 0.125,
p = 0.50) (Figure 3). Best fit lines indicated that in a school
with an arithmetic mean infection intensity of, for example 300
EPG, two Kato-Katzs had 90% sensitivity, whereas in a school
with an arithmetic mean infection intensity of 100 EPG, at
least four Kato-Katzs were required for 90% sensitivity
(Figure 3).
At baseline, the agreement between two Kato-Katzs and six
Kato-Katzs was almost perfect (k= 0.82), however at all other
times the agreements were only substantial or moderate. The
sensitivity of two Kato-Katzs was not significantly different to the
‘gold standard’ (p= 0.15) at baseline, but was significantly lower at
all other times (p,0.001 to 0.03).
POC-CCA. POC-CCA-t+ had a high sensitivity at baseline of
91.7%, but a low sensitivity at one- and four-weeks-post-
praziquantel of 66.7% and 73.0% respectively (Table 3). Sensi-
tivity returned to baseline levels by six-months-post-praziquantel
at 92.0% (Table 3). POC-CCA specificity varied with time since
praziquantel (Table 3). Only one of the 19 children classified as
negative by six Kato-Katzs had a negative POC-CCA result six-
months-post-praziquantel. All POC-CCA-t2 and -t+ PPVs were
$80% except at four-weeks-post-praziquantel. Conversely, the
NPVs were continuously low except at four-weeks-post-prazi-
quantel. POC-CCA-t+ showed a moderate agreement with the
‘gold standard’ at baseline (k= 0.42), but at all other time-points,
only poor or no agreement. POC-CCA-t2 showed a fair
agreement at baseline and six-months-one-week (k= 0.34), but a
moderate agreement at four-weeks (k= 0.44). POC-CCA-t+
results were significantly different from six Kato-Katzs at
one-week, four-weeks and six-months (all p#0.01). POC-CCA-
t2 results were significantly different from six Kato-Katzs at all
time-points except four-weeks-post-praziquantel (all p#0.02).
Effect of Diagnostic Test on Treatment Efficacy and
Reinfection
Observed cure (measured at four-weeks-post-praziquantel
treatment) and reinfection (measured at six-months) rates
depended on sampling method and effort (Figures 4 and 5).
Two Kato-Katzs underestimated S. mansoni reinfection whilst
overestimating CRs (Figure 4A) (two Kato-Katzs CR = 81.5%; six
Kato-Katzs CR = 70.4%). Cure rates determined with POC-
CCA-t2 were 47.8% and 26.1% for POC-CCA-t+. One-week-
post-recent-praziquantel (from data at both one-week and six-
months-one-week), prevalence was significantly lower when
measured by POC-CCAs than by six Kato-Katzs (Figure 4B)
(OR 0.33 (95% CI: 0.19, 0.59).
Pre-re/treatment and at four-weeks-post-praziquantel-re/treat-
ment in years zero, one, and two, the number of days of Kato-
Katzs did not significantly affect the infection intensities (Figure 5)
(all p.0.05). However, at one-week-post-re/treatment (one-week,
six-months-one-week, one-year-one-week and two-years-one-
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week), two Kato-Katzs and to a lesser extent four Kato-Katzs
systematically, and significantly, overestimated the mean infection
intensity (Friedman x2 = 33.08, d.f. = 2, p,0.001).
Infection intensity measured by the strength of the POC-CCA
bands (graded from negative, + (inc. trace), ++ and +++) did not
accurately predict the six Kato-Katzs infection intensity categories
(negative, light, moderate, and heavy) (Table S1). However, strong
positive correlations were seen between the ordinal POC-CCA
band strengths and Kato-Katzs infection intensity categories
(baseline: r = 0.402, p= 0.003; one-week: r = 0.647, p,0.001;
four-weeks: r = 0.389, p= 0.001; six-months: r = 0.413, p,0.001;
six-months-one-week: r = 0.424, p,0.001) as well as between
POC-CCA band strengths and individual arithmetic mean EPG
(Figures 6A to E).
Six Kato-Katzs and POC-CCA as the ‘Gold Standard’
Pre-treatment, one POC-CCA-t+, and two Kato-Katzs had
sensitivities above 90%, however the POC-CCA-t2 and t+ NPVs
were extremely low, similar to one Kato-Katz (Table 3). At one-
week-post-praziquantel, one POC-CCA was less sensitive and had
lower NPVs than one Kato-Katz, whilst two Kato-Katzs had an
NPV of only 55.6%. At four-weeks-post-praziquantel POC-CCA-
t+ had high sensitivity and NPV (.80%), whilst POC-CCA-t2
and one to six Kato-Katzs all had sensitivities and NPVs of,60%.
Indeed, two Kato-Katzs only detected a quarter of the infections.
At six-months-post-praziquantel POC-CCA-t+ was more sensitive
than six Kato-Katzs, however all diagnostics showed NPV values
below 15%.
Effect of Individual Child’s Praziquantel Treatment on
Test Accuracies
Some Bugoto and Bwondha children had been treated once
before the study and new praziquantel-naı¨ve cohorts were
recruited each year. We therefore also analyzed our data along
timelines specific for each individual child’s praziquantel exposure
(Tables S2 and S3). Key results were not affected by re-analyzing
the data in this manner. Pre-treatment, six-months, one-year and
one-year-six-months POC-CCA-t+s showed high sensitivities but
low NPVs throughout (Table S2). One-week-post-recent-prazi-
quantel, three Kato-Katzs were required for .90% sensitivity in
general, and four-weeks-post-recent-praziquantel four or five
Kato-Katzs were required for .90% sensitivities (Table S3). An
increased Kato-Katz sampling effort was required year on year to
achieve sensitivities of .90% (Table S3), which was not clearly
seen in the original M&E timeline (Figure 2, Table 2). Praziquan-
tel-naı¨ve children and children one-year-post-praziquantel re-
quired three Kato-Katzs for accurate S. mansoni diagnosis, whilst
four Kato-Katzs were required at two-years, and five Kato-Katzs
at three-years.
Discussion
We evaluated one to six Kato-Katzs and one POC-CCA for S.
mansoni diagnosis before and after multiple rounds of praziquantel
treatment, and how test choice affects M&E and drug-efficacy
interpretations. Our data support using one POC-CCA-t+ or two
Kato-Katzs for pre-treatment mapping in high endemicity areas
[35–37]. However, as MDA continues, five Kato-Katzs were
required for diagnosis of children after three to ten praziquantel
treatments, particularly pertinent with the Ugandan control
program already in its 11th year. The sensitivity of two Kato-
Katzs was low four-weeks-post-praziquantel treatment indicating
that, if using this method, half the individuals would erroneously
indicate a cured/negative infection. The high sensitivity of two
Kato-Katzs and their agreement with the ‘gold standard’ observed
at baseline was not maintained over time and with recurring
praziquantel treatments. Indeed, such high sensitivity and
agreement was not observed again throughout this study.
POC-CCAs are shown to be more sensitive but less specific than
two Kato-Katzs [33,37,45,46]. Our data show that one POC-
CCA-t+ at four-weeks-post-praziquantel for praziquantel-efficacy
studies and six-months-post-praziquantel for M&E, was more
sensitive than six Kato-Katzs at the same time periods. Our POC-
CCA-t+ baseline sensitivity (91.7%), from a 94.8% S. mansoni
prevalence population, was comparable with that previously
Figure 3. Effect of S. mansoni arithmetic mean infection intensity on sensitivity of one to five Kato-Katzs. The sensitivity of one to five
Kato-Katz thick smears (1KK to 5KK) for diagnosing S. mansoni infections at a range of community arithmetic mean S. mansoni infection intensities
(measured as eggs per gram of stool (EPG) from six Kato-Katz thick smears). S. mansoni infection intensities were measured at three primary schools,
at 11 time points each, ranging from pre-treatment to two-years-four-weeks-post-praziquantel treatment. Lines are best fit linear lines.
doi:10.1371/journal.pntd.0003139.g003
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published from Coˆte d’Ivoire (sensitivity = 86.9%, preva-
lence = 91.8%) [33]. In contrast, our 73% sensitivity at four-
weeks-post-praziquantel (prevalence = 34.2%) was greater than in
the low prevalence Coˆte d’Ivoire region (sensitivity = 56.3%,
prevalence = 32.9%) [33]. This may be explained by that study’s
rigorous nine Kato-Katzs ‘gold standard’, with our six Kato-Katzs
possibly still missing infections. In addition, in Coˆte d’Ivoire, three
POC-CCAs were performed, increasing sensitivity, in comparison
with our single POC-CCA [33]. The lack of POC-CCA
reproducibility data, even from single urine samples [35], are a
key limitation of our study. Though utilizing matching compo-
nents, our accuracies from European Veterinary Laboratory
POC-CCAs, may vary from the Rapid Medical Diagnostics’
POC-CCAs used in Coˆte d’Ivoire, however differences were not
observed at higher prevalence.
At four-weeks-post-praziquantel, prevalence levels as indicated
by six Kato-Katzs and one POC-CCA was nearly double (61.8%)
than for just six Kato-Katzs (34.2%). Cure rates using two
Kato-Katzs were .80% versus 70% with six Kato-Katzs, and
only ,25% with POC-CCA-t+. Similar results have been seen for
S. haematobium [47]. Further discordance between Kato-Katzs
and POC-CCA at six-months (specificity of 5.3%) may be
explained by high numbers of infections missed by Kato-Katzs.
It is unlikely that POC-CCA false positives are the full explanation
due to high specificity at four-weeks-post-praziquantel treatment,
with potentially more ‘true’ negatives and only 1% of POC-CCA
giving false positives in non-endemic areas [35]. We believe that
the low POC-CCA specificities are, in part, due to low sensitivities
of Kato-Katzs.
When six Kato-Katzs and one POC-CCA were the combined
‘gold standard’, baseline and one-week accuracies were relatively
unaffected. Four-weeks-post-praziquantel Kato-Katzs sensitivities
were substantially lower, having profound implications on what is
a suitable ‘gold standard’ when communities have received
multiple praziquantel treatments. Latent class modeling [35,36],
with additional diagnostics [39] overcome theoretical difficulties,
Figure 4. Effect of diagnostic technique and sampling effort on S. mansoni prevalence measures. The effect of (A) number of Kato-Katz
thick smears (Kato-Katzs), from one to six (1KK to 6KK) on the recorded prevalence of S. mansoni infection with multiple praziquantel treatments. All
individuals were treated after sampling at pre, six-months, one-year and two-years. All individuals excreting more than 100 EPG at one-week and any
infected children at all other time-points were re-treated. 95% confidence intervals are excluded for clarity. Difference in sensitivities between the
current standard two Kato-Katzs and our ‘gold standard’ of six Kato-Katzs determined by the McNemar test is significant at all time-points except
baseline. The effect of (B) diagnosis method using six Kato-Katzs or one point-of-care circulating cathodic antigen test (POC-CCA), with a trace
counting as either a positive (POC-CCA-t+) or negative (POC-CCA-t2) on S. mansoni infection prevalence with 95% confidence intervals. Difference in
sensitivities between the POC-CCA and our ‘gold standard’ of six Kato-Katzs determined by the McNemar test: * significant for POC-CCA-t2 or {
significant POC-CCA-t+.
doi:10.1371/journal.pntd.0003139.g004
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but is not fully applicable in praziquantel-efficacy studies,
providing weighted prevalence rather than individual infection
and clearance data.
Studies from the same region in Uganda demonstrating reduced
S. mansoni infection prevalence and intensity levels in response to
MDA [42,48], used only two Kato-Katzs and may have
overestimated annual reductions [37]. We strongly recommend,
as treatment campaigns continue, increased sampling efforts and/
or alternative tools to accurately record program success and CRs,
to detect early drug-resistance indicators, as for STHs [49]. The
need for a higher number of Kato-Katzs for accurate diagnosis as
the number of previous praziquantel treatments increases is not
unexpected considering the small amount of stool used in each
Kato-Katz and the progressively lower egg counts. Our baseline
data indicated that two Kato-Katzs had a sensitivity of .90%,
whereas in contrast, praziquantel-naı¨ve individuals (Table S3)
required four Kato-Katzs for accurate predictions. This apparent
conflicting result may be explained by the high number of
praziquantel-naı¨ve recruits each year, sampled after several
school-based MDA rounds, lowering infection intensities through
reduced force-of-infections [50], supported by Figure 3, where
Kato-Katz sensitivities decrease with EPG.
S. mansoni infection intensities were not expected to vary with Kato-
Katz sampling effort. However, one-week-post annual or biannual
treatment, mean intensities decreased from day one to day three, likely
due to continued daily reductions in egg excretion post treatment. This,
and our discordant POC-CCA and Kato-Katzs results post treatment,
raise interesting questions regarding parasite antigen and egg
clearance, such as residual-egg clearance (with individuals with
intensities of .100 EPG at one-week, not retreated, but negative at
four-weeks), praziquantel-induced fecundity compensation and/or
increased egg expulsion (with higher EPGs at one-week-day-one, than
at baseline, as also observed in S. haematobium [51]).
In contrast, at four-weeks-post-praziquantel, positive POC-
CCA results in egg negative individuals may have occurred due to
juveniles unaffected by treatment, newly acquired infections, and/
or worms which survived treatment, but with reduced or cessated
egg production (embryostasis). Drug-induced embryostasis, has
been demonstrated in Onchocerca volvulus [52] and Ascaris suum
[53]. Embryostasis could explain our lower sensitivities (73%) at
four-weeks-post-praziquantel than those observed in a stable, low
transmission Western Kenyan region (prevalence 38.8%, sensitiv-
ity = 96%) [34]. In this Kenyan region a large proportion of
individuals may be truly negative with no egg or antigen
excretions. Embryostasis could significantly affect drug-resistance
selection, with worms repeatedly exposed to praziquantel, without
dying or being detected by standard parasitological techniques.
Being impossible to sample adult worms directly, studies on worm
antigens, egg production and molecular studies incorporating
sibship analyses informing adult breeding numbers [54,55] post-
praziquantel treatment may elucidate this.
As intensities decrease, costs of accurate diagnoses by Kato-
Katzs will rise due to greater sampling requirements. Diagnoses
using urine, rather than stool, remain quicker, cheaper on labor
costs, more convenient, socially acceptable and may improve
compliance [35]. In low endemicity areas, pooled urine samples
for POC-CCAs could reduce costs further. However, key POC-
CCA limitations are their inability to detect STHs, and inaccuracy
measuring infection intensities and treatment resolutions. Multiple
smears from one stool (versus multiple stools) and FLOTAC [49]
may be viable diagnostic alternatives. If one sampling day can
accurately detect schistosomiasis and STH infection intensities and
ERRs, it may be highly cost-effective, warranting further research.
As the geographical distribution of STH infections are more
homogeneous than schistosomiasis, WHO recommends surveys of
smaller subsets of schools for mapping and M&E [15]. We
therefore recommend widespread POC-CCA use, with Kato-
Katzs performed in a subsection of schools. For drug-efficacy
studies we recommend at least six Kato-Katzs or one POC-CCA,
with further research on clearance dynamics of eggs and antigens
post treatment needed.
Conclusions
At least four Kato-Katzs (two smears per stool from two stools) are
required for M&E, in the early years of a MDA program in a highly
endemic area, increasing to six Kato-Katzs (two smears per stool
from three stools) by year three. One POC-CCA is a suitable
alternative to current prevalence M&E protocols, but they provide no
Figure 5. S. mansoni intensity measures from one to three days of duplicate Kato-Katz thick smears. Data shown over multiple rounds of
praziquantel treatments with standard error bars.
doi:10.1371/journal.pntd.0003139.g005
Test Accuracy for S. mansoni Diagnosis Pre- and Post-treatment
PLOS Neglected Tropical Diseases | www.plosntds.org 12 September 2014 | Volume 8 | Issue 9 | e3139
information on STHs and limited intensity data post treatment,
therefore we recommend their use for S. mansoni M&E with Kato-
Katzs performed in a subset of schools. For drug-efficacy studies, at
least six Kato-Katzs (two smears per stool from three stools) are
required for accurate prevalence assessment four-weeks-post-prazi-
quantel treatment. POC-CCAs may be a promising alternative with
low specificity findings potentially due to low Kato-Katzs sensitivity,
however further work is required to elucidate POC-CCA’s full
potential for drug-efficacy studies. Further work on improved ‘gold
standards’ is required to elucidate discordant POC-CCA and Kato-
Katzs results. Data on multiple Kato-Katzs from a single stool post-
treatment would ascertain if accuracies of multiple days of
Kato-Katzs or POC-CCAs could be matched, minimizing logistical
costs without overestimating M&E success and drug efficacy, whilst
retaining vitally important intensity data.
Supporting Information
Checklist S1 STARD checklist.
(DOC)
Table S1 S. mansoni infection intensity categories by
six Kato-Katzs and a single POC-CCA. Proportion of World
Health Organization infection intensity categories, as measured by
six Kato-Katz thick smears, which are correctly identified by a
Figures 6. Comparison of S. mansoni arithmetic mean intensity measured by six Kato-Katzs with POC-CCA band strength. S. mansoni
mean intensity in eggs per gram of stool (EPG) in comparison to the band strengths of a single urine point-of-care circulating cathodic antigen test
(CCA) at five time-points, from (A) pre-treatment at baseline, (B) one-week-post-, (C) four-weeks-post-, (D) six-months-post- and (E) six-months-one-
week-post-praziquantel treatment. Spearman’s rank coefficients and significance values are given for each time point. Trace readings were included
in the + category. NB y axes vary.
doi:10.1371/journal.pntd.0003139.g006
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single point-of-care circulating cathodic antigen test (POC-CCA)
band strength, ranging from negative to three. Tests were
performed pre-treatment (Baseline), one-week-post- (1 Wk), four-
weeks-post- (4 Wks), six-months-post- (6 Mths) and six-months-
one-week-post- (6 Mths 1 Wk) praziquantel treatment. Percentage
of tests correctly identified in parentheses.
(DOCX)
Table S2 Accuracy of one to five Kato-Katzs and a single
POC-CCA for diagnosing S. mansoni infections over
time since each child was first treated with praziquan-
tel. The accuracy of one to five Kato-Katz thick smears (1KK to
5KK) and a single point-of-care circulating cathodic antigen test
(POC-CCA) (comparing if trace readings are counted as positive
(POC-CCA-t+) or negative (POC-CCA-t2)) for detecting S.
mansoni infection over the time since each child was first treated
with praziquantel (10 time-points, in real time from the start of this
study) with six Kato-Katz thick smears (6KK) as the ‘gold
standard’. Sens = sensitivity, Spec = specificity, NPV = negative
predictive value, PPV = positive predictive value.
(DOCX)
Table S3 The accuracy of one to five Kato-Katzs for
detecting S. mansoni infection over time since each child
was first treated with praziquantel. The accuracy of one to
five Kato-Katz thick smears (1KK to 5KK) for detecting S.
mansoni infection over time since each child was first treated with
praziquantel (16 time-points, in real time from the start of this
study) compared with the ‘gold standard’ of six Kato-Katzs (6KK),
from the complete dataset of children who each had results from
six Kato-Katz thick smears (n = 1065). Proportion infected given
in parentheses, as measured by six Kato-Katz thick smears,
although it should be noted that this is a hypothetical prevalence as
the actual time-points of data collection vary from the time since
each child was first exposed to praziquantel. Sens = sensitivity,
Spec = specificity, NPV = negative predictive value.
(DOCX)
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